The mechanism involved in the process was that COL1A2 expression was elevated by the transcription factor TWIST1, and EP300 was recruited near the promoter of COL1A2 to increase its H3K27ac modification, leading to COL1A2 overexpression and apatinib resistance in GC cells. The gene discussed is EP300; the disease is gastric cancer.